Redox regulation of phagocyte NOX2 in inflammation and aging
Redox regulation of phagocyte NOX2 in inflammation and aging
批准号:
7931541
负责人:
ROBERT A CLARK
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2014-06-30
关键词:
ABL1 geneAgeAgingAging-Related ProcessAutoimmunityBindingBiochemicalBiological AssayBiological ProcessBiology of AgingCalciumCationsCell AgingCell membraneCellsCellular biologyCharacteristicsChronicChronic Granulomatous DiseaseComplexDataDeteriorationDiseaseDrug or chemical Tissue DistributionElderlyElementsEnzymesEventFamilyFeedbackFunctional disorderGTP-Binding ProteinsGene ExpressionGene FamilyGenerationsGenesGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHereditary DiseaseHomologous GeneHost DefenseHumanHydrogen PeroxideImmuneIn VitroIndividualInfectionInflammationInflammatoryInjuryInvadedLaboratoriesLeadLeukocytesLinear ModelsMalignant NeoplasmsMeasuresMediatingMembraneMicrobeMolecularMolecular BiologyMorbidity - disease rateMyelogenousNADPH OxidaseNADPH Oxidase 1Natural ImmunityOxidasesOxidation-ReductionOxidative StressOxidoreductasePathway interactionsPatientsPatternPerformancePhagocytesPhenotypePhosphorylationPhosphotransferasesPlayPredispositionProtein ChemistryProtein IsoformsProtein Tyrosine KinaseProteinsPublicationsReactive Oxygen SpeciesReagentRecurrenceRegulationRegulatory PathwayResearchRoleSRC geneSeriesSignal PathwaySignal TransductionSignal Transduction PathwaySmall Interfering RNASourceStimulusSuperoxidesSystemTRPC3 ion channelTechniquesTestingTissuesTyrosineTyrosine PhosphorylationTyrosine Phosphorylation SiteWorkabstractingage relatedantimicrobialbasec-abl Proto-Oncogenescytochrome b558designfeedingfrailtyhuman CYBA proteinhuman subjectin vivoinflammatory markerinnovationinterestkillingsmembermicrobicidemicroorganismmonocytemortalitymutantneutrophilneutrophil cytosol factor 67Knovelprogramsresearch studyresponserho GTP-Binding Proteinssulfated glycoprotein 2superoxide-generating NADPH oxidasetranscription factorvoltageyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Project Summary / Abstract Neutrophils comprise the first line of host defense, killing invading microbes by generating reactive oxygen species (ROS) through an activatable NADPH oxidase system. This respiratory burst oxidase is genetically absent in patients with chronic granulomatous disease, resulting in recurring severe infections with high morbidity and mortality. The phagocyte oxidase features membrane-bound catalytic components (gp91phox/p22phox) and cytosolic co-factors (p47phox, p67phox, Rac1/2) that undergo stimulus-dependent translocation during assembly of the active NADPH oxidase. Recently, it has been found that gp91phox is actually the founder of the 7-member NOX/DUOX gene family, each homologue having its characteristic pattern of tissue expression and functional role. We have recently demonstrated a novel feed-forward regulation of NOX5 by hydrogen peroxide (H2O2) acting through a signaling pathway involving calcium and the non-receptor tyrosine kinase c-Abl. Especially relevant to the current proposal are our preliminary data suggesting that a related pathway exists for the phagocyte NADPH oxidase (NOX2) and that this pathway is dysregulated with aging, a biological process associated with ROS and oxidative stress. Our main objectives are to characterize the regulation of NOX2 in human phagocytic cells by H2O2 and to assess the relevance of such regulation to chronic inflammation and aging. Our hypothesis is that H2O2 is a common regulator of the NOX enzymes through specific redox-mediated signaling pathways and that this mechanism is dysregulated during aging. Three specific aims will guide the work. Aim 1 is to dissect the proximal elements of this signal transduction pathway as a means of defining the early targets of H2O2, focusing on the H2O2-activated Ca2+ channels involved, the mechanisms of channel regulation, and the signaling intermediates, especially protein tyrosine kinases (PTKs), that are directly regulated by Ca2+ influx. Aim 2 is to investigate the intermediates that lead from H2O2-activated PTKs (c-Abl, c-Src) to assembly and activation of NOX2, considering the role of specific PKC isotypes, the mechanism of activation of Rac GTPase, and the direct tyrosine phosphorylation of NOX2. Aim 3 is to examine the status and role of H2O2-NOX2 regulation in human phagocytic leukocytes as a function of age, including both cross-sectional and longitudinal assessment of NOX2-mediated superoxide generation, correlation with biochemical and functional markers of the aging phenotype, and mechanistic exploration of the signaling pathways defined in Aims 1 and 2. The studies proposed are innovative because they capitalize on our novel observations on redox regulation of NOX, and take advantage of key reagents, constructs, and cells, as well as extensive preliminary data and the broad-based expertise of our research team. The experiments will use state-of-the-art techniques in cell biology, protein chemistry, and molecular biology. The scientific significance of our proposal is that it has the potential for establishing broadly applicable precedents for the cell biology of ROS generation, host defenses, and cell signaling, as well as aging-associated ROS dysregulation.
PUBLIC HEALTH RELEVANCE:
Project Narrative The veterans health relevance of this proposal is that the results are likely to have significant implications for a variety of diseases that are highly prevalent in veterans, as well as in the general population. NOX2- derived toxic reactive oxygen species are presently known to be involved in the pathogenesis of a number of disorders, including among others atherosclerosis, myocardial infarction, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (Lou Gehrig's disease), and ischemic stroke. Moreover, there is convincing evidence that NOX-derived toxic oxygen products are involved in the aging process. Since this project will address regulation of the production of the damaging forms of oxygen that mediate such disorders, there is considerable potential for improved understanding, as well as the identification of new targets for therapeutic intervention for the benefit of patients with these diseases, as well as for the amelioration of certain aspects of the aging process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:10704865
-
项目类别:
-
资助金额:$563.56万
-
财政年份:2023
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:10487947
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2022
-
负责人:ROBERT A CLARK
-
依托单位:
Development of Sustainable Reporting to the National COVID Cohort Collaborative (N3C)
-
批准号:10244205
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2020
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:10404497
-
项目类别:
-
资助金额:$391.93万
-
财政年份:2018
-
负责人:ROBERT A CLARK
-
依托单位:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
-
批准号:10408715
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ROBERT A CLARK
-
依托单位:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
-
批准号:10254880
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ROBERT A CLARK
-
依托单位:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
-
批准号:9137152
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ROBERT A CLARK
-
依托单位:
Pilot and Exploratory Studies Core (PESC)
-
批准号:10670129
-
项目类别:
-
资助金额:$21.54万
-
财政年份:2015
-
负责人:ROBERT A CLARK
-
依托单位:
Pilot and Exploratory Studies Core (PESC)
-
批准号:10221555
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2015
-
负责人:ROBERT A CLARK
-
依托单位:
Pilot and Exploratory Studies Core (PESC)
-
批准号:10455766
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2015
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8877665
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8721515
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:9069131
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8877666
-
项目类别:
-
资助金额:$356.46万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:9282323
-
项目类别:
-
资助金额:$292.86万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:9069129
-
项目类别:
-
资助金额:$332.53万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8743361
-
项目类别:
-
资助金额:$70.3万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8916918
-
项目类别:
-
资助金额:$10.95万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8743363
-
项目类别:
-
资助金额:$402.3万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
-
批准号:8721518
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2013
-
负责人:ROBERT A CLARK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: